Absence of tight junctions between microvascular endothelial cells in human cerebellar hemangioblastomas

Neurosurgery

Volumn 59, Issue 3, 2006, Pages 660-669

  Chen, Yizhao ^a,b   Tachibana, Osamu ^a   Hasegawa, Mitsuhiro ^a   Xu, Ruxiang ^c   Hamada, Jun Ichiro ^a   Yamashita, Junkoh ^a   Hashimoto, Nobuo ^b   Takahashi, Jun A ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Cyst; Hemangioblastoma; Tight junction

Indexed keywords

CLAUDIN 5; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; ASTROCYTE; CEREBELLUM TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FEMALE; HEMANGIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; WESTERN BLOTTING;

ADULT; BLOOD-BRAIN BARRIER; CEREBELLAR NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; HEMANGIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIGHT JUNCTIONS;

EID: 33748532817     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000223372.18607.D7     Document Type: Article

References (44)

1. Andras IE, Pu H, Tian J, Deli MA, Nath A, Hennig B, Toborek M: Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J Cereb Blood Flow Metab 25:1159-1170, 2005.
2. Arthur FE, Shivers RR, Bowman PD: Astrocyte-mediated induction of tight junctions in brain capillary endothelium: An efficient in vitro model. Brain Res 433:155-159, 1987.
3. Ballabh P, Braun A, Nedergaard M: The blood-brain barrier: An overview - Structure, regulation, and clinical implications. Neurobiol Dis 16:1-13, 2004.
4. Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, de Vries EG: The blood-brain barrier and oncology: New insights into function and modulation. Cancer Treat Rev 26:449-462, 2000.
5. Bertossi M, Virgintino D, Maiorano E, Occhiogrosso M, Roncali L: Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 21:41-49, 1997.
6. Butt AM, Jones HC, Abbott NJ: Electrical resistance across the blood-brain barrier in anaesthetized rats: A developmental study. J Physiol 429:47-62, 1990.
7. Chen Y, Tachibana O, Oda M, Xu R, Hamada J, Yamashita J, Hashimoto N, Takahashi J: Increased expression of aquaporin 1 in human hemangioblastomas and its correlation with cyst formation. J Neurooncol (in press).
8. Davies DC: Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200:639-646, 2002.
9. Fischer S, Wobben M, Marti HH, Renz D, Schaper W: Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 63:70-80, 2002.
10. Furuse M, Sasaki H, Fujimoto K, Tsukita S: A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 143:391-401, 1998.
11. Ge S, Song L, Pachter JS: Where is the blood-brain barrier . . . really. J Neurosci Res 79:421-427, 2005.
12. Go KG, Hew JM, Kamman RL, Molenaar WM, Pruim J, Blaauw EH: Cystic lesions of the brain. A classification based on pathogenesis, with consideration of histological and radiological features. Eur J Radiol 17:69-84, 1993.
13. Goldstein GW, Betz AL: Recent advances in understanding brain capillary function. Ann Neurol 14:389-395, 1983.
14. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol 81:1-44, 2003.
15. Haorah J, Heilman D, Knipe B, Chrastil J, Leibhart J, Ghorpade A, Miller DW, Persidsky Y: Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcohol Clin Exp Res 29:999-1009, 2005.
16. Harhaj NS, Antonetti DA: Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36:1206-1237, 2004.
17. Huber JD, Egleton RD, Davis TP: Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719-725, 2001.
18. Julow J, Balint K, Gortvai P, Pasztor E: Posterior fossa haemangioblastomas. Acta Neurochir (Wien) 128:109-114, 1994.
19. Kitajima Y, Endo T, Nagasawa K, Manase K, Honnma H, Baba T, Hayashi T, Chiba H, Sawada N, Saito T: Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5. Endocrinology 147:694-699, 2006.
20. Leung SY, Chan AS, Wong MP, Yuen ST, Cheung N, Chung LP: Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma. Am J Surg Pathol 21:941-950, 1997.
21. Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, Wolburg H: Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (Berl) 100:323-331, 2000.
22. Lohle PN, Verhagen IT, Teelken AW, Blaauw EH, Go KG: The pathogenesis of cerebral gliomatous cysts. Neurosurgery 30:180-185, 1992.
23. Lohle PN, Wurzer HA, Seelen PJ, Kingma LM, Go KG: The pathogenesis of cysts accompanying intra-axial primary and metastatic tumors of the central nervous system. J Neurooncol 40:277-285, 1998.
24. Lohmann C, Krischke M, Wegener J, Galla HJ: Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and independent pathways. Brain Res 995: 184-196, 2004.
25. Niemela M, Lemeta S, Summanen P, Bohling T, Sainio M, Kere J, Poussa K, Sankila R, Haapasalo H, Kaariainen H, Pukkala E, Jääskeläinen J: Long-term prognosis of haemangioblastoma of the CNS: Impact of von Hippel-Lindau disease. Acta Neurochir (Wien) 141:1147-1156, 1999.
26. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S: Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-660, 2003.
27. Papadopoulos MC, Saadoun S, Davies DC, Bell BA: Emerging molecular mechanisms of brain tumour oedema. Br J Neurosurg 15:101-108, 2001.
28. Pedram A, Razandi M, Levin ER: Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. J Biol Chem 277:44385-44398, 2002.
29. Resche F, Moisan JP, Mantoura J, de Kersaint-Gilly A, Andre MJ, Perrin-Resche I, Menegalli-Boggelli D, Lajat Y, Richard S: Haemangioblastoma, haemangioblastomatosis, and von Hippel-Lindau disease. Adv Tech Stand Neurosurg 20:197-304, 1993.
30. Sawada T, Kato Y, Kobayashi M, Takekekawa Y: Immunohistochemical study of tight junction-related protein in neovasculature in astrocytic tumor. Brain Tumor Pathol 17:1-6, 2000.
31. Schmitt M, Horbach A, Kubitz R, Frilling A, Haussinger D: Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): A novel mechanism for tumor invasion. J Hepatol 41:274-283, 2004.
32. Stockhammer G, Obwegeser A, Kostron H, Schumacher P, Muigg A, Felber S, Maier H, Slavc I, Gunsilius E, Gastl G: Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. Acta Neuropathol (Berl) 100:101-105, 2000.
33. Vaquero J, Zurita M, Oya S, Coca S, Salas C: Vascular permeability factor expression in cerebellar hemangioblastomas: Correlation with tumor-associated cysts. J Neurooncol 41:3-7, 1999.
34. Vorbrodt AW, Dobrogowska DH: Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: Electron microscopist's view. Brain Res Brain Res Rev 42:221-242, 2003.
35. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82-94, 2003.
36. Wang W, Dentler WL, Borchardt RT: VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 280:H434-H440, 2001.
37. Watson PM, Anderson JM, Vanltallie CM, Doctrow SR: The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers. Neurosci Lett 129:6-10, 1991.
38. Weindel K, Moringlane JR, Marme D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis. Neurosurgery 35:439-448, 1994.
39. Wells WA, Bonetta L: Endothelial tight junctions form the blood-brain barrier. J Cell Biol 169:378, 2005.
40. Willis CL, Leach L, Clarke GJ, Nolan CC, Ray DE: Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss. Glia 48:1-13, 2004.
41. Wolburg H, Neuhaus J, Kniesel U, Krauss B, Schmid EM, Ocalan M, Farrell C, Risau W: Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci 107:1347-1357, 1994.
42. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B: Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol (Berl) 105:586-592, 2003.
43. Yamashita J, Handa H, Kim C, Kim S: Familial occurrence of cerebellar hemangioblastomas: Analysis of five families. Neurosurgery 11:761-763, 1982.
44. Young S, Richardson AE: Solid haemangioblastomas of the posterior fossa: Radiological features and results of surgery. J Neurol Neurosurg Psychiatry 50:155-158, 1987.